Synthesis and Antimicrobial Activity of Short Analogues of the Marine Antimicrobial Peptide Turgencin A: Effects of SAR Optimizations, Cys-Cys Cyclization and Lipopeptide Modifications

We have synthesised short analogues of the marine antimicrobial peptide Turgencin A from the colonial Arctic ascidian Synoicum turgens. In this study, we focused on a central, cationic 12-residue Cys-Cys loop region within the sequence. Modified (tryptophan- and arginine-enriched) linear peptides we...

Full description

Bibliographic Details
Published in:International Journal of Molecular Sciences
Main Authors: Dey, Hymonti, Simonovic, Danijela, Hagen, Ingrid Sofie Norberg-Schulz, Vasskog, Terje, Fredheim, Elizabeth G. Aarag, Blencke, Hans-Matti, Anderssen, Trude, Strøm, Morten B., Haug, Tor
Format: Article in Journal/Newspaper
Language:English
Published: MDPI 2022
Subjects:
VDP::Matematikk og naturvitenskap: 400::Kjemi: 440::Legemiddelkjemi: 448
VDP::Mathematics and natural scienses: 400::Chemistry: 440::Pharmaceutical chemistry: 448
Mikrobiologi / Microbiology
Arctic
Online Access:https://hdl.handle.net/10037/27420
https://doi.org/10.3390/ijms232213844
Description
Summary:We have synthesised short analogues of the marine antimicrobial peptide Turgencin A from the colonial Arctic ascidian Synoicum turgens. In this study, we focused on a central, cationic 12-residue Cys-Cys loop region within the sequence. Modified (tryptophan- and arginine-enriched) linear peptides were compared with Cys-Cys cyclic derivatives, and both linear and Cys-cyclic peptides were N-terminally acylated with octanoic acid (C 8 ), decanoic acid (C 10 ) or dodecanoic acid (C 12 ). The highest antimicrobial potency was achieved by introducing dodecanoic acid to a cyclic Turgencin A analogue with low intrinsic hydrophobicity, and by introducing octanoic acid to a cyclic analogue displaying a higher intrinsic hydrophobicity. Among all tested synthetic Turgencin A lipopeptide analogues, the most promising candidates regarding both antimicrobial and haemolytic activity were C 12 -cTurg-1 and C 8 -cTurg-2. These optimized cyclic lipopeptides displayed minimum inhibitory concentrations of 4 µg/mL against Staphylococcus aureus, Escherichia coli and the fungus Rhodothorula sp. Mode of action studies on bacteria showed a rapid membrane disruption and bactericidal effect of the cyclic lipopeptides. Haemolytic activity against human erythrocytes was low, indicating favorable selective targeting of bacterial cells.

Similar Items